Hope for Coronavirus Vaccine Grows With Biotech Company’s Research Results

The biotech company Moderna Therapeutics just announced promising results from its Coronavirus vaccine research. Dr. Stephen Hoge told CBS News that research subjects who had received two doses of the vaccine “had seroconverted to develop antibodies in their blood that bound the virus.” Dr. Hoge said the treatment could “neutralize the virus.” Although this is good news, CBS News contributor Dr. David Agus pointed out “there’s a long way to go in that particular vaccine.”